S&P 500   0.56 (+5.04%)
DOW   0.56 (+5.04%)
QQQ   269.38 (+1.35%)
AAPL   435.75 (+2.52%)
MSFT   216.54 (+5.62%)
FB   251.96 (-0.67%)
GOOGL   1,482.76 (-0.35%)
AMZN   3,111.89 (-1.67%)
NVDA   440.41 (+3.73%)
CGC   19.06 (+4.27%)
BABA   257.94 (+2.76%)
TSLA   1,485.00 (+3.79%)
MU   50.39 (+0.68%)
GE   6.11 (+0.66%)
AMD   77.67 (+0.31%)
T   29.62 (+0.14%)
F   6.69 (+1.21%)
ACB   10.42 (+2.26%)
GILD   71.73 (+3.16%)
NFLX   498.62 (+1.99%)
DIS   116.35 (-0.50%)
BAC   24.99 (+0.44%)
BA   162.27 (+2.70%)
S&P 500   0.56 (+5.04%)
DOW   0.56 (+5.04%)
QQQ   269.38 (+1.35%)
AAPL   435.75 (+2.52%)
MSFT   216.54 (+5.62%)
FB   251.96 (-0.67%)
GOOGL   1,482.76 (-0.35%)
AMZN   3,111.89 (-1.67%)
NVDA   440.41 (+3.73%)
CGC   19.06 (+4.27%)
BABA   257.94 (+2.76%)
TSLA   1,485.00 (+3.79%)
MU   50.39 (+0.68%)
GE   6.11 (+0.66%)
AMD   77.67 (+0.31%)
T   29.62 (+0.14%)
F   6.69 (+1.21%)
ACB   10.42 (+2.26%)
GILD   71.73 (+3.16%)
NFLX   498.62 (+1.99%)
DIS   116.35 (-0.50%)
BAC   24.99 (+0.44%)
BA   162.27 (+2.70%)
S&P 500   0.56 (+5.04%)
DOW   0.56 (+5.04%)
QQQ   269.38 (+1.35%)
AAPL   435.75 (+2.52%)
MSFT   216.54 (+5.62%)
FB   251.96 (-0.67%)
GOOGL   1,482.76 (-0.35%)
AMZN   3,111.89 (-1.67%)
NVDA   440.41 (+3.73%)
CGC   19.06 (+4.27%)
BABA   257.94 (+2.76%)
TSLA   1,485.00 (+3.79%)
MU   50.39 (+0.68%)
GE   6.11 (+0.66%)
AMD   77.67 (+0.31%)
T   29.62 (+0.14%)
F   6.69 (+1.21%)
ACB   10.42 (+2.26%)
GILD   71.73 (+3.16%)
NFLX   498.62 (+1.99%)
DIS   116.35 (-0.50%)
BAC   24.99 (+0.44%)
BA   162.27 (+2.70%)
S&P 500   0.56 (+5.04%)
DOW   0.56 (+5.04%)
QQQ   269.38 (+1.35%)
AAPL   435.75 (+2.52%)
MSFT   216.54 (+5.62%)
FB   251.96 (-0.67%)
GOOGL   1,482.76 (-0.35%)
AMZN   3,111.89 (-1.67%)
NVDA   440.41 (+3.73%)
CGC   19.06 (+4.27%)
BABA   257.94 (+2.76%)
TSLA   1,485.00 (+3.79%)
MU   50.39 (+0.68%)
GE   6.11 (+0.66%)
AMD   77.67 (+0.31%)
T   29.62 (+0.14%)
F   6.69 (+1.21%)
ACB   10.42 (+2.26%)
GILD   71.73 (+3.16%)
NFLX   498.62 (+1.99%)
DIS   116.35 (-0.50%)
BAC   24.99 (+0.44%)
BA   162.27 (+2.70%)
Log in

NYSE:PBHPrestige Consumer Healthcare Stock Price, Forecast & News

$38.08
+0.89 (+2.39 %)
(As of 08/3/2020 04:00 PM ET)
Add
Compare
Today's Range
$37.40
Now: $38.08
$38.30
50-Day Range
$35.61
MA: $38.01
$40.75
52-Week Range
$27.40
Now: $38.08
$46.12
Volume420,724 shs
Average Volume501,947 shs
Market Capitalization$1.91 billion
P/E Ratio13.70
Dividend YieldN/A
Beta0.78
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare and household cleaning products in North America, Australia, and internationally. It operates in three segments: North American OTC Healthcare, International OTC Healthcare, and Household Cleaning. The company's OTC healthcare products include BC/Goody's analgesic powders, Beano for gas prevention, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids/lozenges, Clear Eyes for eye allergy/redness relief, Compound W for wart removal, Debrox for ear wax removal, DenTek PEG oral care, Dramamine for motion sickness relief, and Efferdent denture cleanser tablets. Its OTC healthcare products portfolio also comprises Fess nasal saline spray, Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Hydralyte for oral rehydration, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Pedia-Lax pediatric laxatives, Summer's Eve for feminine hygiene, Little Remedies pediatric OTC products, and The Doctor's NightGuard dental protectors. In addition, the company offers household cleaning products, such as abrasive tub and tile cleaners under the Comet name, as well as Chore Boy, and Spic and Span names. It serves mass merchandisers; and drug, food, dollar, convenience, and club stores. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.
Read More
Prestige Consumer Healthcare logo

Beat the Market (BTM) Rank

Analyst Opinion: 4.1Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.76 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryPersonal Products
CUSIP74112D10
Phone914-524-6800

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$963.01 million
Cash Flow$3.75 per share
Book Value$23.30 per share

Profitability

Net Income$142.28 million

Miscellaneous

Employees530
Market Cap$1.91 billion
Next Earnings Date8/6/2020 (Confirmed)
OptionableOptionable
$38.08
+0.89 (+2.39 %)
(As of 08/3/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive PBH News and Ratings via Email

Sign-up to receive the latest news and ratings for PBH and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Prestige Consumer Healthcare (NYSE:PBH) Frequently Asked Questions

How has Prestige Consumer Healthcare's stock been impacted by COVID-19 (Coronavirus)?

Prestige Consumer Healthcare's stock was trading at $35.91 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, PBH shares have increased by 6.0% and is now trading at $38.08.
View which stocks have been most impacted by Coronavirus
.

Do Wall Street analysts recommend investors buy shares of Prestige Consumer Healthcare?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Prestige Consumer Healthcare in the last year. There are currently 5 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Prestige Consumer Healthcare
.

When is Prestige Consumer Healthcare's next earnings date?

Prestige Consumer Healthcare is scheduled to release its next quarterly earnings announcement on Thursday, August 6th 2020.
View our earnings forecast for Prestige Consumer Healthcare
.

How can I listen to Prestige Consumer Healthcare's earnings call?

Prestige Consumer Healthcare will be holding an earnings conference call on Thursday, August 6th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Prestige Consumer Healthcare's earnings last quarter?

Prestige Consumer Healthcare Inc (NYSE:PBH) announced its quarterly earnings data on Thursday, May, 7th. The company reported $0.82 earnings per share for the quarter, topping the Zacks' consensus estimate of $0.74 by $0.08. The firm had revenue of $251.20 million for the quarter, compared to analysts' expectations of $239.65 million. Prestige Consumer Healthcare had a net margin of 14.77% and a return on equity of 13.33%. Prestige Consumer Healthcare's revenue for the quarter was up 4.2% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.72 EPS.
View Prestige Consumer Healthcare's earnings history
.

What guidance has Prestige Consumer Healthcare issued on next quarter's earnings?

Prestige Consumer Healthcare updated its first quarter earnings guidance on Thursday, May, 7th. The company provided EPS guidance of $0.70 or more for the period, compared to the Thomson Reuters consensus EPS estimate of $0.69. The company issued revenue guidance of ~$220 million or more, compared to the consensus revenue estimate of $232.21 million.

What price target have analysts set for PBH?

7 equities research analysts have issued twelve-month price objectives for Prestige Consumer Healthcare's shares. Their forecasts range from $43.00 to $97.00. On average, they anticipate Prestige Consumer Healthcare's share price to reach $69.33 in the next twelve months. This suggests a possible upside of 82.1% from the stock's current price.
View analysts' price targets for Prestige Consumer Healthcare
.

Has Prestige Consumer Healthcare been receiving favorable news coverage?

News stories about PBH stock have been trending negative this week, InfoTrie Sentiment reports. The research group identifies positive and negative news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Prestige Consumer Healthcare earned a media sentiment score of -2.9 on InfoTrie's scale. They also gave media stories about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the company's share price in the near term.
View the latest news about Prestige Consumer Healthcare
.

Are investors shorting Prestige Consumer Healthcare?

Prestige Consumer Healthcare saw a increase in short interest in July. As of July 15th, there was short interest totaling 5,670,000 shares, an increase of 5.8% from the June 30th total of 5,360,000 shares. Based on an average trading volume of 459,500 shares, the days-to-cover ratio is currently 12.3 days. Approximately 11.4% of the company's stock are short sold.
View Prestige Consumer Healthcare's Current Options Chain
.

Who are some of Prestige Consumer Healthcare's key competitors?

What other stocks do shareholders of Prestige Consumer Healthcare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Prestige Consumer Healthcare investors own include Gilead Sciences (GILD), AbbVie (ABBV), GW Pharmaceuticals PLC- (GWPH), Johnson & Johnson (JNJ), TG Therapeutics (TGTX), Flexion Therapeutics (FLXN), Marathon Petroleum (MPC), Pfizer (PFE), AT&T (T) and Thermo Fisher Scientific (TMO).

Who are Prestige Consumer Healthcare's key executives?

Prestige Consumer Healthcare's management team includes the following people:
  • Mr. Ronald M. Lombardi, Chairman, Pres & CEO (Age 55)
  • Ms. Christine Sacco, Chief Financial Officer (Age 43)
  • Mr. William C. P'Pool, Sr. VP, Gen. Counsel & Corp. Sec. (Age 54)
  • Mr. Timothy J. Connors, Exec. VP of Sales & Marketing (Age 52)
  • Mr. Jeff Zerillo, Sr. VP of Operations

What is Prestige Consumer Healthcare's stock symbol?

Prestige Consumer Healthcare trades on the New York Stock Exchange (NYSE) under the ticker symbol "PBH."

Who are Prestige Consumer Healthcare's major shareholders?

Prestige Consumer Healthcare's stock is owned by a variety of retail and institutional investors. Top institutional investors include Dalton Greiner Hartman Maher & Co. (0.60%), Wedge Capital Management L L P NC (0.55%), North Star Asset Management Inc. (0.52%), Peregrine Capital Management LLC (0.30%), UBS Group AG (0.27%) and NN Investment Partners Holdings N.V. (0.22%). Company insiders that own Prestige Consumer Healthcare stock include Paton Brett, Ronald M Lombardi and Timothy Connors.
View institutional ownership trends for Prestige Consumer Healthcare
.

Which institutional investors are selling Prestige Consumer Healthcare stock?

PBH stock was sold by a variety of institutional investors in the last quarter, including NN Investment Partners Holdings N.V., NN Investment Partners Holdings N.V., Dalton Greiner Hartman Maher & Co., Skyline Asset Management LP, Dupont Capital Management Corp, Denali Advisors LLC, North Star Asset Management Inc., and Vident Investment Advisory LLC.
View insider buying and selling activity for Prestige Consumer Healthcare
.

Which institutional investors are buying Prestige Consumer Healthcare stock?

PBH stock was bought by a variety of institutional investors in the last quarter, including UBS Group AG, First Trust Advisors LP, Duality Advisers LP, Mackay Shields LLC, Lapides Asset Management LLC, Nisa Investment Advisors LLC, Wedge Capital Management L L P NC, and Wakefield Asset Management LLLP.
View insider buying and selling activity for Prestige Consumer Healthcare
.

How do I buy shares of Prestige Consumer Healthcare?

Shares of PBH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Prestige Consumer Healthcare's stock price today?

One share of PBH stock can currently be purchased for approximately $38.08.

How big of a company is Prestige Consumer Healthcare?

Prestige Consumer Healthcare has a market capitalization of $1.91 billion and generates $963.01 million in revenue each year. The company earns $142.28 million in net income (profit) each year or $2.96 on an earnings per share basis. Prestige Consumer Healthcare employs 530 workers across the globe.

What is Prestige Consumer Healthcare's official website?

The official website for Prestige Consumer Healthcare is www.prestigebrands.com.

How can I contact Prestige Consumer Healthcare?

Prestige Consumer Healthcare's mailing address is 660 WHITE PLAINS ROAD SUITE 250, TARRYTOWN NY, 10591. The company can be reached via phone at 914-524-6800 or via email at [email protected]

This page was last updated on 8/3/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.